Name | (E)-N-methyl-N-[(3-methyl-1-benzofuran-2-yl)methyl]-3-(7-oxo-6,8-dihydro-5H-1,8-naphthyridin-3-yl)prop-2-enamide |
---|---|
Synonyms |
afn-1252
unii-t3o718ikkm api-1252 |
Description | AFN-1252(Debio 1452) is a potent inhibitor of enoyl-acyl carrier protein reductase (FabI), inhibited all clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis at concentrations of ≤0.12 μg/ml. IC50 value:Target: Antibiotic agentAFN-1252 was inactive (MIC90, >4 μg/ml) against clinical isolates of Streptococcus pneumoniae, beta-hemolytic streptococci, Enterococcus spp., Enterobacteriaceae, nonfermentative gram-negative bacilli, and Moraxella catarrhalis. These data support the continued development of AFN-1252 for the treatment of patients with resistant staphylococcal infections. |
---|---|
Related Catalog | |
References |
Molecular Formula | C22H21N3O3 |
---|---|
Molecular Weight | 375.42000 |
Exact Mass | 375.15800 |
PSA | 78.93000 |
LogP | 3.77780 |
Storage condition | 2-8℃ |